These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 26387747)

  • 61. [Use of metformin in the management of adolescents with polycystic ovary syndrome].
    Zárate A; Hernández M; Fonseca ME; Ochoa R
    Ginecol Obstet Mex; 1997 Dec; 65():504-7. PubMed ID: 9477644
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Effects of metformin and ethinyl estradiol-cyproterone acetate on lipid levels in obese and non-obese women with polycystic ovary syndrome.
    Rautio K; Tapanainen JS; Ruokonen A; Morin-Papunen LC
    Eur J Endocrinol; 2005 Feb; 152(2):269-75. PubMed ID: 15745936
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Decreased serum leptin concentrations during metformin therapy in obese women with polycystic ovary syndrome.
    Morin-Papunen LC; Koivunen RM; Tomás C; Ruokonen A; Martikainen HK
    J Clin Endocrinol Metab; 1998 Jul; 83(7):2566-8. PubMed ID: 9661644
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Anti-Müllerian hormone in women with polycystic ovary syndrome before and after therapy with metformin.
    Tomova A; Deepinder F; Robeva R; Kirilov G; Mechandjiev Z; Kumanov P
    Horm Metab Res; 2011 Sep; 43(10):723-7. PubMed ID: 21932178
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Effect of metformin, orlistat and pioglitazone treatment on mean insulin resistance and its biological variability in polycystic ovary syndrome.
    Cho LW; Kilpatrick ES; Keevil BG; Coady AM; Atkin SL
    Clin Endocrinol (Oxf); 2009 Feb; 70(2):233-7. PubMed ID: 18547343
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Metformin versus metformin plus rosiglitazone in women with polycystic ovary syndrome.
    Liao L; Tian YJ; Zhao JJ; Xin Y; Xing HY; Dong JJ
    Chin Med J (Engl); 2011 Mar; 124(5):714-8. PubMed ID: 21518564
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Homocysteine levels in women with polycystic ovary syndrome treated with metformin versus rosiglitazone: a randomized study.
    Kilicdag EB; Bagis T; Zeyneloglu HB; Tarim E; Aslan E; Haydardedeoglu B; Erkanli S
    Hum Reprod; 2005 Apr; 20(4):894-9. PubMed ID: 15618250
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Weight loss significantly reduces serum lipocalin-2 levels in overweight and obese women with polycystic ovary syndrome.
    Koiou E; Tziomalos K; Katsikis I; Kandaraki EA; Kalaitzakis E; Delkos D; Vosnakis C; Panidis D
    Gynecol Endocrinol; 2012 Jan; 28(1):20-4. PubMed ID: 21756081
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Short-term metformin treatment for clomiphene citrate-resistant women with polycystic ovary syndrome.
    Kazerooni T; Ghaffarpasand F; Kazerooni Y; Kazerooni M; Setoodeh S
    Int J Gynaecol Obstet; 2009 Oct; 107(1):50-3. PubMed ID: 19552904
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Impact of metformin on anti-Müllerian hormone in women with polycystic ovary syndrome: a secondary analysis of a randomized controlled trial.
    Madsen HN; Lauszus FF; Trolle B; Ingerslev HJ; Tørring N
    Acta Obstet Gynecol Scand; 2015 May; 94(5):547-51. PubMed ID: 25736975
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Clinical, endocrine and metabolic effects of metformin vs N-acetyl-cysteine in women with polycystic ovary syndrome.
    Oner G; Muderris II
    Eur J Obstet Gynecol Reprod Biol; 2011 Nov; 159(1):127-31. PubMed ID: 21831508
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Calcium plus vitamin D supplementation affects glucose metabolism and lipid concentrations in overweight and obese vitamin D deficient women with polycystic ovary syndrome.
    Asemi Z; Foroozanfard F; Hashemi T; Bahmani F; Jamilian M; Esmaillzadeh A
    Clin Nutr; 2015 Aug; 34(4):586-92. PubMed ID: 25300649
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Combined lifestyle modification and metformin in obese patients with polycystic ovary syndrome. A randomized, placebo-controlled, double-blind multicentre study.
    Tang T; Glanville J; Hayden CJ; White D; Barth JH; Balen AH
    Hum Reprod; 2006 Jan; 21(1):80-9. PubMed ID: 16199429
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The effects of metformin on endothelial dysfunction, lipid metabolism and oxidative stress in women with polycystic ovary syndrome.
    Kocer D; Bayram F; Diri H
    Gynecol Endocrinol; 2014 May; 30(5):367-71. PubMed ID: 24517721
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Metformin, an efficacious drug in the treatment of polycystic ovary syndrome].
    Hahn S; Quadbeck B; Elsenbruch S; Gärtner R; Finke R; Mann K; Janssen OE
    Dtsch Med Wochenschr; 2004 May; 129(19):1059-64. PubMed ID: 15136950
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Comparison of myo-inositol and metformin on glycemic control, lipid profiles, and gene expression related to insulin and lipid metabolism in women with polycystic ovary syndrome: a randomized controlled clinical trial.
    Shokrpour M; Foroozanfard F; Afshar Ebrahimi F; Vahedpoor Z; Aghadavod E; Ghaderi A; Asemi Z
    Gynecol Endocrinol; 2019 May; 35(5):406-411. PubMed ID: 30608001
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Metformin improves menstrual patterns, endocrine and metabolic profile in obese hyperinsulinemic women with a polycystic ovary syndrome.
    Krstevska B; Dimitrovski Ch; Pemovska G; Misevska S; Dimova Z; Simeonova S; Ahmeti I
    Prilozi; 2006 Jul; 27(1):57-66. PubMed ID: 16862066
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Effect of metformin treatment on endometrial vascular indices in anovulatory obese/overweight women with polycystic ovarian syndrome using three-dimensional power doppler ultrasonography.
    Mohsen IA; Elkattan E; Nabil H; Khattab S
    J Clin Ultrasound; 2013 Jun; 41(5):275-82. PubMed ID: 23124626
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Improvement in endothelial structure and function after metformin treatment in young normal-weight women with polycystic ovary syndrome: results of a 6-month study.
    Orio F; Palomba S; Cascella T; De Simone B; Manguso F; Savastano S; Russo T; Tolino A; Zullo F; Lombardi G; Azziz R; Colao A
    J Clin Endocrinol Metab; 2005 Nov; 90(11):6072-6. PubMed ID: 16118336
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A pilot trial of metformin for insulin resistance and mood disturbances in adolescent and adult women with polycystic ovary syndrome.
    Erensoy H; Niafar M; Ghafarzadeh S; Aghamohammadzadeh N; Nader ND
    Gynecol Endocrinol; 2019 Jan; 35(1):72-75. PubMed ID: 30182764
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.